Logotype for Black Diamond Therapeutics Inc

Black Diamond Therapeutics (BDTX) Proxy filing summary

Event summary combining transcript, slides, and related documents.

Logotype for Black Diamond Therapeutics Inc

Proxy filing summary

29 Apr, 2026

Voting matters and shareholder proposals

  • Election of two Class III directors, Shannon Campbell and Kapil Dhingra, both recommended by the board for approval.

  • Ratification of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026.

  • Advisory vote to approve the compensation of named executive officers, with a board recommendation to vote in favor.

  • Advisory vote on the preferred frequency of future say-on-pay votes, with a recommendation for an annual (1 year) frequency.

  • Board will consider any other business that may properly come before the meeting or any adjournment.

Board of directors and corporate governance

  • Board recommends the election of two Class III directors at the 2026 annual meeting.

Executive compensation and say-on-pay

  • Advisory vote on executive compensation is included, with board support for approval.

  • Shareholders are asked to indicate preferred frequency for future say-on-pay votes, with a recommendation for annual votes.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more